United States · Bill · HR
H.R. 4212 (103rd)
Biotechnology Stimulus Act of 1994
Introduced
14 April 1994
Last action
—
Status
Sponsor introductory remarks on measure. (CR H2590)
Sponsors
—
Subjects
Discovery layer
Source updated
26 August 2025
Summary
Biotechnology Stimulus Act of 1994 - Amends the Internal Revenue Code with regard to the biotechnology research credit to: (1) establish an alternative credit calculation based on aggregate research expenses; and (2) make the credit permanent. Establishes: (1) a biotechnology variable capital gains deduction; and (2) a capital gains exclusion for biotechnology startup business stock held for more than two years. Provides for the indexing of certain capital assets for purposes of gain or loss determinations. Expresses the sense of the Congress that accounting standards should not be changed to require that biotechnology businesses deduct the value of stock options from their profits.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 14 April 1994
Introduced in House (PDF)
Introduced in House · EN · 14 April 1994
Introduced in House
summary · EN · 14 April 1994
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/4212
- Open data entity: https://api.congress.gov/v3/bill/103/hr/4212